Ibrahim Abubakar

Last updated
Ibrahim Abubakar
FMedSci FRCP FFPH
Ibrahim Abubakar.jpg
NationalityBritish
Alma mater London School of Hygiene & Tropical Medicine
University of Cambridge
University of East Anglia
Scientific career
Fields Epidemiology and global health
Institutions University College London
University of East Anglia
Thesis An epidemiological investigation of the role of mycobacterium avium subspecies paratuberculosis in the aetiology of Chrohn's disease  (2007)
Website https://iris.ucl.ac.uk/iris/browse/profile?upi=IABUB15

Ibrahim Ibrahim Abubakar is a British-Nigerian epidemiologist who is Professor in Infectious Disease Epidemiology, Pro-Provost (Health) [1] and Dean of the Faculty of Population Health Sciences [2] [3] [4] at University College London.

Contents

Education

He qualified in medicine in 1992 from Ahmadu Bello University and initially trained in general medicine before specialising in public health medicine. [5] He trained in public health at the London School of Hygiene and Tropical Medicine graduating with an MSc in 1999, DPH from the University of Cambridge in 2000 and a PhD from the University of East Anglia in 2007. [6]

Work

He was director of the UCL Institute for Global Health until August 2021. [7] He previously served as head of TB at Public Health England. [8] Prior to his appointment at UCL, he was Professor in Health Protection at Norwich Medical School. In 2011, he was awarded a Senior Research Fellowship by the National Institute for Health and Care Research (NIHR) on tuberculosis [9] and in 2016 he was appointed as an NIHR Senior Investigator. [10]

He was elected to the Fellowship of the Academy of Medical Sciences in 2020 in recognition of his research in infectious disease epidemiology and migration and health. [11]

He is the chair of the NIHR Global Professorship Selection Committee, [12] the NIHR Senior Investigator Medical and Dental Sub-Committee [13] and the Lancet Migration Initiative. [14] He was an Advisory Board member of the Public Health Board of Open Society Foundation [15] and of the MRC Applied Global Health Board. [16] He is also on the Editorial Board of BMC Medicine. [17]

He is a non-executive member of the North Central London Integrated Care Board [18] and a member of the Global Preparedness Monitoring Board. [19]

He served as the chair of the WHO Strategic and Technical Advisory Group for Tuberculosis (STAG TB) from 2016 to 2019 [20] and co-chaired the NICE TB guidelines development group, [21] and was a board member, Africa Research Excellence Fund. [22]

In 2023, the Institute for Health Metrics and Evaluation awarded Professor Abubaker the Roux Prize for his dedication to improving health outcomes over the prior three decades. [23]

Research and publications

Abubakar led the Lancet Nigeria Commission [24] which was launched in March 2022 in Abuja with media coverage [25] and has influenced national health policy in Nigeria including the recent passage of the National Health Insurance Authority Act 2022. [26] He led the UCL-Lancet Commission on Migration and Health [27] which dispelled myths regarding the perceived threat from migration to public health and urged action on improved health provision for migrants. The results were especially topical in the context of mass migration in the Mediterranean and in central and North America. The findings of the commission achieved widespread media coverage, such as reports in The Guardian, NBC News, and at the World Economic Forum. [28] [29] [30] In 2022, he co-edited a textbook on refugee health. [31]

He co-edited the Oxford Specialist Handbook in Infectious Disease Epidemiology published in 2016. [32] His work on mass gathering medicine in 2012 as part of the Lancet infectious Diseases Mass Gathering Medicine Series [33] generated media interest due to the potential impact of pandemics in crowded settings (London 2012: Mass gathering risks disease spreading). [34]

He is widely published in tuberculosis epidemiology, diagnosis and control with media coverage including research on tuberculosis screening, [35] work showing high risk of TB in pregnancy and the postpartum period, tuberculosis and air travel, [36] and on the effects of BCG in TB prevention. [37] He leads the E-DETECT TB project in Europe for the early detection of tuberculosis, [38] which in Romania has led to the expansion of mobile x-ray screening through €15 million investment in similar units to travel around the country. [39] He is currently the coordinator of the END-VOC EU funded international consortium of cohort studies on covid-19 variants. [40]

He has an h-index of 96 according to Google Scholar. [41]

Other activities

Related Research Articles

<span class="mw-page-title-main">Tropical medicine</span> Interdisciplinary branch of medicine

Tropical medicine is an interdisciplinary branch of medicine that deals with health issues that occur uniquely, are more widespread, or are more difficult to control in tropical and subtropical regions.

Professor John Grange died 10 October 2016 was an English immunologist, epidemiologist, researcher, and academic, and was one of Europe's leading tuberculosis specialists.

<span class="mw-page-title-main">Mario Raviglione</span>

Mario C. B. Raviglione has been professor at the University of Milan, Italy since March 2018. He directs the activities focused on global health and aiming at pursuing didactic and research in this field as part of the new Multidisciplinary Research in Health Science (MACH) Centre. Part of his activities are devoted to teaching global health principles to undergraduate medical students, making the University of Milan the first in Italy, and one of the pioneers world-wide, introducing global health as a module among the required curricular courses. At the same university, Raviglione is now coordinating the first international Master Course in Global Health in Italy and one of the very few online worldwide . In 2019 and 2020, he was also Professeur Titulaire at the Global Studies Institute (GSI), Université de Genève, Suisse. Through the GSI, he has worked within the context of the Institute of Global Health. Previously, between 2003 and 2017, he was director of the Global Tuberculosis Programme at the World Health Organization (WHO) . He graduated in medicine from the University of Turin in 1980 and then trained in internal medicine and Infectious Diseases at Cabrini Medical Center in New York City and at Beth Israel Medical Center in Boston where he was a Harvard University Clinical Fellow in Medicine and specialised in AIDS. Back in Europe, Raviglione joined WHO in 1991 as a Junior Professional Officer, and spent a few years working on TB and AIDS, TB epidemiology in Europe, and anti-TB drug resistance surveillance and response. In the mid-1990s, he set up both the WHO global drug resistance surveillance project and the WHO global TB surveillance and monitoring systems. Among his major achievements are the contributions to the development of the WHO's DOTS Strategy in 1995, and the direction of the development of both the Stop TB Strategy in 2006 and the End TB Strategy in 2014. During his years at WHO he worked with, and visited, more than 50 countries supporting their TB care, prevention, control and research activities. His research work has resulted in over 350 scientific articles and chapters on the topics of infectious diseases, HIV/AIDS, TB, and global health, including the TB chapters in the last eight editions of Harrison's Principles of Internal Medicine. He is editor of the 3rd and 4th edition of "Tuberculosis - A comprehensive international approach", a multi-author book, and associate editor of other books on public health, infectious diseases and tuberculosis. He directed the team that developed the book “Systematic screening for active tuberculosis – Principles and recommendations”, awarded by the British Medical Association as "Highly Commended Book" for Public Health in 2014. He is among the top 10 most cited authors in the TB field. His h-index is 117 and 94 (Scinapse) and his work has been cited over 63000 times. He is also among the top 25 Italian epidemiological scientists and the top 100 Italian scientists in general. As an expert in TB, he has worked as a teacher or visiting professor at Johns Hopkins University, University of Geneva, University of Modena and Reggio Emilia, and University of Pavia. He has been visiting professor at the University of Brescia and has recently lectured at major universities including Harvard, McGill and Sydney. He participates in a variety of board of directors, scientific and advisory committees, including those of the TB Alliance, Doctors with Africa CUAMM, BE Health Association, International Health Commission of the Missionary Sisters of the Sacred Heart - Cabrini Ministries ,Fondazione 3Bi. and the McGill Global Health Programs International Advisory Board. In 2017-2018 and in 2023 he was member of the Lancet Commission on TB. During 2015-2017 he conceived and co-organised, with WHO and the Russian Federation Ministry of Health, the first Global WHO Ministerial Conference on TB in the Sustainable Development Era, held in Moscow on 16–17 November 2017, and his team worked towards ensuring that TB is raised in the international political agenda through the United Nations General Assembly high-level meeting on TB that was held in 2018. As main Editor, he conceived and coordinated with other global health authorities the publication of a landmark book "Global Health Essentials" part of the Springer series devoted to the UN Sustainable Development Goals (SDGs). This practical manual is a comprehensive book written by an esteemed international panel of over 150 experts from 70 institutions across 30 countries, and provides a succinct yet thorough exploration of key global health challenges, issues, and solutions.

<span class="mw-page-title-main">Alimuddin Zumla</span> British-Zambian physician

Sir Alimuddin Zumla is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.

<span class="mw-page-title-main">Andrew Hayward</span> University academic into infectious disease epidemiology

Andrew C Hayward is professor of infectious disease epidemiology and inclusion health research at University College London.

Dame Anne Mandall Johnson DBE FMedSci is a British epidemiologist, known for her work in public health, especially the areas of HIV, sexually transmitted infections and infectious diseases.

Francisca Mutapi is a Professor in Global Health Infection and Immunity, co-Director of the Global Health Academy at the University of Edinburgh, and Deputy Director of the National Institute for Health Research (NIHR) Global Health Research Unit Tackling Infections to Benefit Africa. She is the first black woman known to have been awarded a professorship by the University of Edinburgh.

Graham Cooke is a clinician scientist and NIHR Professor of Infectious Diseases at the Wright-Fleming Institute of Imperial College London. He is best known for his work on viral hepatitis, particularly hepatitis C.

<span class="mw-page-title-main">Tolullah Oni</span> Nigerian urban epidemiologist

Tolullah "Tolu" Oni is a Nigerian urban epidemiologist at the Medical Research Council Epidemiology Unit at the University of Cambridge. She is a NextEinstein Forum Fellow and World Economic Forum Young Global Leader.

<span class="mw-page-title-main">Helen McShane</span> British virologist

Helen Irene McShane is a British infectious disease physician and a professor of vaccinology, in the Jenner Institute at the University of Oxford, where she has led the tuberculosis vaccine research group since 2001. She is senior research fellow at Harris Manchester College, Oxford.

<span class="mw-page-title-main">Chikwe Ihekweazu</span> Nigerian epidemiologist

Chikwe Ihekweazu is a Nigerian epidemiologist, public health physician and the World Health Organization's Assistant Director-General for Health Emergency Intelligence and Surveillance Systems.

Rosalind Raine is a British applied health research scientist, public medicine doctor, professor of health care evaluation and the founding head of the Department of Applied Health Research at University College London (UCL).

Elizabeth Lucy Corbett is a British epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.

Alison Helen Holmes is a British infectious diseases specialist, who is a professor at Imperial College London and the University of Liverpool. Holmes serves as Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance and Consultant at Hammersmith Hospital. Holmes is on the Executive Committee of the International Society of Infectious Diseases, and she serves on a variety of World Health Organization (WHO) expert groups related to antimicrobial use, Antimicrobial Resistance (AMR), infection prevention and sepsis. Her research considers how to mitigate antimicrobial resistance.

Daisy Fancourt is a British researcher who is a professor of psychobiology and epidemiology at University College London. Her research focuses on the effects of social factors on health, including loneliness, social isolation, community assets, arts and cultural engagement, and social prescribing. During the COVID-19 pandemic Fancourt led a team running the UK's largest study into the psychological and social impact of COVID-19 and established the international network COVID Minds, aiming to better understand the impact of coronavirus disease on mental health and well-being. In She is listed by Clarivate as one of the most highly cited and influential scientists in the world.

Russell Mardon Viner, FMedSci is an Australian-British paediatrician and policy researcher who is Chief Scientific Advisor at the Department for Education and Professor of Adolescent Health at the UCL Great Ormond Street Institute of Child Health. He is an expert on child and adolescent health in the UK and internationally. He was a member of the UK Government's Scientific Advisory Group for Emergencies (SAGE) during the COVID-19 pandemic and was President of the Royal College of Paediatrics and Child Health from 2018 to 2021. He remains clinically active, seeing young people with diabetes each week at UCL Hospitals. Viner is vice-chair of the NHS England Transformation Board for Children and Young People and Chair of the Stakeholder Council for the Board. He is a non-executive director (NED) at Great Ormond St. Hospital for Children NHS Foundation Trust, also sitting on the Trust's Finance & Investment and the Quality and Safety sub-committees.

Megan Blanche Murray is an American epidemiologist and an infectious disease physician. She is the Ronda Stryker and William Johnston Professor of Global Health in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.

<span class="mw-page-title-main">Martin Rossor</span>

Martin Neil Rossor is a British clinical neurologist with a specialty interest in degenerative dementias and familial disease.

Madhukar Pai is an Indian medical doctor, academic, advocate, writer, and university professor. Pai's work is around global health, specifically advocacy for better treatment for tuberculosis with a focus on South Africa and India. Pai is the inaugural Chair of the Department of Global and Public Health in the School of Population and Global Health and holds a Canada Research Chair in Epidemiology and Global Health at McGill University.

Ifedayo Morayo Adetifa, a Nigerian paediatrician and infectious diseases epidemiologist, is the current Director General of the Nigeria Centre for Disease Control (NCDC). He was appointed to this role in September 2021 by President Muhammadu Buhari to replace Dr. Chikwe Ihekweazu who was the head of the agency since August 2016.

References

  1. ↑ UCL (6 December 2023). "Professor Ibrahim Abubakar". UCL. Retrieved 12 July 2024.
  2. ↑ UCL (22 June 2018). "Professor Ibrahim Abubakar". UCL-TB. Retrieved 16 July 2020.
  3. ↑ "Ibrahim-Abubakar-appointed-as-dean". ucl.ac.uk. 12 May 2021. Retrieved 2022-08-12.
  4. ↑ "Iris View Profile". iris.ucl.ac.uk. Retrieved 2020-09-09.
  5. ↑ "Iris View Profile". iris.ucl.ac.uk. Retrieved 2020-09-09.
  6. ↑ "Iris View Profile". iris.ucl.ac.uk. Retrieved 2020-09-09.
  7. ↑ "Ibrahim-Abubakar-appointed-as-dean". ucl.ac.uk. 12 May 2021. Retrieved 2022-08-12.
  8. ↑ "Ibrahim Abubakar - Public health matters". publichealthmatters.blog.gov.uk. Retrieved 2020-09-09.
  9. ↑ "NIHR Funding and Awards Search Website". www.dev.fundingawards.nihr.ac.uk. Retrieved 2020-09-09.
  10. ↑ "NIHR Annual Report" (PDF). National Institute for Health Research. Archived from the original (PDF) on 2020-07-25. Retrieved 2020-09-09.
  11. ↑ "50 leading biomedical and health scientists elected to the prestigious Academy Fellowship | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 2020-09-09.
  12. ↑ "NIHR Research Professorships". nihr.ac.uk. Retrieved 2022-08-12.
  13. ↑ "NIHR Senior Investigator Committee". nihr.ac.uk. Retrieved 2024-07-12.
  14. ↑ "OUR TEAM". migrationandhealth. Retrieved 2020-09-09.
  15. ↑ "Public Health Program, Global Health Advisory Committee". www.opensocietyfoundations.org. Archived from the original on 2020-09-28. Retrieved 2020-09-09.
  16. ↑ "Medical Research Council Applied Global Health Board". mrc.ukri.org. 2022-03-31. Retrieved 2022-08-12.
  17. ↑ "BMC Medicine". BMC Medicine. Retrieved 2020-09-09.
  18. ↑ "NCL ICB". NCL ICB. Retrieved 2024-07-12.
  19. ↑ "Global Preparedness Monitoring Board". Global Preparedness Monitoring Board.
  20. ↑ "Strategic and technical advisory group for tuberculosis" (PDF). World Health Organisation. Retrieved 2020-09-09.
  21. ↑ Hoppe, Lucy Elizabeth; Kettle, Rachel; Eisenhut, Michael; Abubakar, Ibrahim (2016-01-13). "Tuberculosis—diagnosis, management, prevention, and control: summary of updated NICE guidance". BMJ. 352: h6747. doi:10.1136/bmj.h6747. ISSN   1756-1833. PMID   26762607. S2CID   206908943.
  22. ↑ "Our Board's biographies • Africa Research Excellence fund". Africa Research Excellence fund. Archived from the original on 2020-07-25. Retrieved 2020-09-09.
  23. ↑ "Professor Ibrahim Abubakar awarded 2023 Roux Prize". The Institute for Health Metrics and Evaluation. Retrieved 2024-08-28.
  24. ↑ "Lancet Nigeria Commission". lancet.com. Retrieved 2022-08-12.
  25. ↑ "Nigeria Health System Requires Radical Overhaul". Financial Times. 16 March 2022. Retrieved 2022-08-12.
  26. ↑ "83 million poor nigerians to benefit from new health insurance". vanguardngr.com. Retrieved 2022-08-12.
  27. ↑ "The UCL–Lancet Commission on Migration and Health: the health of a world on the move". www.thelancet.com. Retrieved 2020-09-09.
  28. ↑ "Myths about migrants spreading disease 'inform hostile policies'". the Guardian. 2018-12-05. Retrieved 2020-09-09.
  29. ↑ "Migrants don't bring disease. In fact, they help fight it, report says". NBC News. 5 December 2018. Retrieved 2020-09-09.
  30. ↑ "Migrants are 'healthier and live longer' than residents in their host countries". World Economic Forum. Retrieved 2020-09-09.
  31. ↑ "Routledge". Routledge. Retrieved 2024-07-12.
  32. ↑ Abubakar, Ibrahim; Stagg, Helen R.; Cohen, Ted; Rodrigues, Laura C., eds. (2016-04-07). Infectious Disease Epidemiology. Oxford, New York: Oxford University Press. ISBN   978-0-19-871983-0.
  33. ↑ "Mass Gatherings Health". www.thelancet.com. Retrieved 2020-09-09.
  34. ↑ "London 2012 'disease spread risk'". BBC News. 2012-01-16. Retrieved 2020-09-09.
  35. ↑ "Despite progress, tuberculosis persists in West European cities". Reuters. 2014-03-07. Retrieved 2020-09-09.
  36. ↑ "Rules for flying with tuberculosis disputed". The Washington Times. Retrieved 2020-09-09.
  37. ↑ "BCG vaccine prevents TB infection in children". GOV.UK. 14 June 2019. Retrieved 2020-09-09.
  38. ↑ Abubakar, Ibrahim; Matteelli, Alberto; Vries, Gerard de; Zenner, Dominik; Cirillo, Daniela M.; Lönnroth, Knut; Popescu, Gilda; Barcellini, Lucia; Story, Alistair; Migliori, Giovanni Battista (2018-05-01). "Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium". European Respiratory Journal. 51 (5). doi: 10.1183/13993003.02604-2017 . ISSN   0903-1936. PMID   29748241.
  39. ↑ ucltb (2019-10-29). "E-DETECT presented at Romanian Parliament". E-DETECT TB. Retrieved 2020-09-09.
  40. ↑ "end-voc". Endvoc. Retrieved 2024-07-12.
  41. ↑ "Ibrahim Abubakar". Google Scholar . Retrieved 8 May 2024.
  42. ↑ Strategy Group on Health Africa Europe Foundation (AEF).
  43. ↑ "Nation Newspaper". Nation Newspaper. Retrieved 2024-07-12.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.